Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial.

Gibson BE, Webb DK, Howman AJ, De Graaf SS, Harrison CJ, Wheatley K; United Kingdom Childhood Leukaemia Working Group and the Dutch Childhood Oncology Group.

Br J Haematol. 2011 Nov;155(3):366-76. doi: 10.1111/j.1365-2141.2011.08851.x. Epub 2011 Sep 9.

PMID:
21902686
2.

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol.

van der Velden VH, van der Sluijs-Geling A, Gibson BE, te Marvelde JG, Hoogeveen PG, Hop WC, Wheatley K, Bierings MB, Schuurhuis GJ, de Graaf SS, van Wering ER, van Dongen JJ.

Leukemia. 2010 Sep;24(9):1599-606. doi: 10.1038/leu.2010.153. Epub 2010 Jul 29.

PMID:
20668473
3.

Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.

Harrison CJ, Hills RK, Moorman AV, Grimwade DJ, Hann I, Webb DK, Wheatley K, de Graaf SS, van den Berg E, Burnett AK, Gibson BE.

J Clin Oncol. 2010 Jun 1;28(16):2674-81. doi: 10.1200/JCO.2009.24.8997. Epub 2010 May 3.

PMID:
20439644
4.

EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.

Balgobind BV, Lugthart S, Hollink IH, Arentsen-Peters ST, van Wering ER, de Graaf SS, Reinhardt D, Creutzig U, Kaspers GJ, de Bont ES, Stary J, Trka J, Zimmermann M, Beverloo HB, Pieters R, Delwel R, Zwaan CM, van den Heuvel-Eibrink MM.

Leukemia. 2010 May;24(5):942-9. doi: 10.1038/leu.2010.47. Epub 2010 Apr 1.

PMID:
20357826
5.

Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings technique.

Balgobind BV, Hollink IH, Reinhardt D, van Wering ER, de Graaf SS, Baruchel A, Stary J, Beverloo HB, de Greef GE, Pieters R, Zwaan CM, van den Heuvel-Eibrink MM.

Eur J Cancer. 2010 Jul;46(10):1892-9. doi: 10.1016/j.ejca.2010.02.019. Epub 2010 Mar 16.

PMID:
20233657
6.

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.

Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, Balgobind BV, Arentsen-Peters ST, Alders M, Willasch A, Kaspers GJ, Trka J, Baruchel A, de Graaf SS, Creutzig U, Pieters R, Reinhardt D, Zwaan CM.

Blood. 2009 Jun 4;113(23):5951-60. doi: 10.1182/blood-2008-09-177949. Epub 2009 Jan 26.

PMID:
19171881
7.

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML.

Hollink IH, Zwaan CM, Zimmermann M, Arentsen-Peters TC, Pieters R, Cloos J, Kaspers GJ, de Graaf SS, Harbott J, Creutzig U, Reinhardt D, van den Heuvel-Eibrink MM, Thiede C.

Leukemia. 2009 Feb;23(2):262-70. doi: 10.1038/leu.2008.313. Epub 2008 Nov 20.

PMID:
19020547
8.

Vincristine pharmacokinetics in children with Down syndrome.

Lönnerholm G, Frost BM, Söderhäll S, de Graaf SS.

Pediatr Blood Cancer. 2009 Jan;52(1):123-5. doi: 10.1002/pbc.21691.

PMID:
18615507
9.

Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia.

Lönnerholm G, Frost BM, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Heyman M, Uges DR, de Graaf SS.

Br J Haematol. 2008 Aug;142(4):616-21. doi: 10.1111/j.1365-2141.2008.07235.x. Epub 2008 Jun 4.

PMID:
18537965
10.

Broncholithiasis in an immune compromised boy with disseminated Mycobacterium kansasii.

Cuppen I, de Lange WC, de Graaf SS, Mol SJ, Boetes C, Yntema JL.

Pediatr Pulmonol. 2007 Oct;42(10):980-3.

PMID:
17722115
11.

Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group.

Dutch Childhood Oncology Group, te Loo DM, Kamps WA, van der Does-van den Berg A, van Wering ER, de Graaf SS.

J Clin Oncol. 2006 May 20;24(15):2332-6.

PMID:
16710032
12.

Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.

Rao A, Hills RK, Stiller C, Gibson BE, de Graaf SS, Hann IM, O'Marcaigh A, Wheatley K, Webb DK.

Br J Haematol. 2006 Mar;132(5):576-83.

PMID:
16445830
13.

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.

Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, De Graaf SS, Harrison CJ.

Leukemia. 2005 Dec;19(12):2130-8.

PMID:
16304572
14.

Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.

Kardos G, Zwaan CM, Kaspers GJ, de-Graaf SS, de Bont ES, Postma A, Bökkerink JP, Weening RS, van der Does-van den Berg A, van Wering ER, Korbijn C, Hählen K.

Leukemia. 2005 Dec;19(12):2063-71.

PMID:
16107896
15.

Pharmacokinetic studies in children with cancer.

Groninger E, Proost JH, de Graaf SS.

Crit Rev Oncol Hematol. 2004 Dec;52(3):173-97. Review.

PMID:
15582785
16.

Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.

Plasschaert SL, Groninger E, Boezen M, Kema I, de Vries EG, Uges D, Veerman AJ, Kamps WA, Vellenga E, de Graaf SS, de Bont ES.

Clin Pharmacol Ther. 2004 Sep;76(3):220-9.

PMID:
15371983
17.
18.

Mycobacterium reverse hybridization line-probe assay used to diagnose disseminated Mycobacterium haemophilum infection in a child with acute lymphoblastic leukemia.

Bosma F, Deckers-Kocken JM, de Graaf SS, Schülin T, Melchers WJ, Hoogkamp-Korstanje JA.

Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):345-7. Epub 2004 Mar 6. No abstract available.

PMID:
15007704
19.

Transient cortical blindness following vincristine therapy.

Schouten D, de Graaf SS, Verrips A.

Med Pediatr Oncol. 2003 Nov;41(5):470. No abstract available.

PMID:
14515391
20.

Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents.

Frost BM, Lönnerholm G, Koopmans P, Abrahamsson J, Behrendtz M, Castor A, Forestier E, Uges DR, de Graaf SS.

Acta Paediatr. 2003 May;92(5):551-7.

PMID:
12839283
21.

Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species?

Groninger E, Meeuwsen-De Boer GJ, De Graaf SS, Kamps WA, De Bont ES.

Int J Oncol. 2002 Dec;21(6):1339-45.

PMID:
12429986
22.

Topical topics: pitfalls of "long-distance pharmacokinetics." Shipment of biologic samples to reference laboratories.

Kellie SJ, Uges DR, Koopmans P, Frost BM, De Graaf SS.

Med Pediatr Oncol. 2002 May;38(5):369-70. No abstract available.

PMID:
11979465
23.

Predictive value of clinical evaluation in the follow-up of children with a brain tumor.

de Graaf N, Hew JM, Fock JM, Kamps WA, de Graaf SS.

Med Pediatr Oncol. 2002 Apr;38(4):254-7.

PMID:
11920789
24.

Cerebrospinal fluid concentrations of vincristine after bolus intravenous dosing: a surrogate marker of brain penetration.

Kellie SJ, Barbaric D, Koopmans P, Earl J, Carr DJ, de Graaf SS.

Cancer. 2002 Mar 15;94(6):1815-20.

25.
26.

Vincristine-induced apoptosis in vivo in peripheral blood mononuclear cells of children with acute lymphoblastic leukaemia (ALL).

Groninger E, de Graaf SS, Meeuwsen-de Boer GJ, Sluiter WJ, Poppema S.

Br J Haematol. 2000 Dec;111(3):875-8.

PMID:
11122150
27.

Reply

de Graaf SS, Cochran PK, Chauvenet AR.

Med Pediatr Oncol. 2000 Nov;35(5):508. No abstract available.

PMID:
11070488
28.

The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models.

Gidding CE, Germain GS, Dilling MB, Meeuwsen-de Boer TG, Ashmun RA, de Graaf SS, Veverka KA, Kamps WA, Houghton PJ.

Cancer Chemother Pharmacol. 2000;45(1):21-30.

PMID:
10647497
29.

Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.

Thompson J, George EO, Poquette CA, Cheshire PJ, Richmond LB, de Graaf SS, Ma M, Stewart CF, Houghton PJ.

Clin Cancer Res. 1999 Nov;5(11):3617-31.

30.

Vincristine pharmacokinetics after repetitive dosing in children.

Gidding CE, Meeuwsen-de Boer GJ, Koopmans P, Uges DR, Kamps WA, de Graaf SS.

Cancer Chemother Pharmacol. 1999;44(3):203-9.

PMID:
10453721
31.

Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor.

Cochran PK, Chauvenet AR, Hart PS, de Graaf SS, Cushing B, Kroovand L, Wofford MM.

Med Pediatr Oncol. 1999 Jun;32(6):436-7. No abstract available.

PMID:
10358703
32.

Vincristine revisited.

Gidding CE, Kellie SJ, Kamps WA, de Graaf SS.

Crit Rev Oncol Hematol. 1999 Feb;29(3):267-87. Review. No abstract available.

PMID:
10226730
33.

Translocation (11;22)(q24;q12) in a small cell tumor of the thigh in a 2-year-old boy: immunohistology, cytogenetics, molecular genetics, and review of the literature.

Mastik MF, Molenaar WM, Plaat BE, de Graaf SS, Hogendoorn PC, van der Hout AH, van den Berg E.

Hum Pathol. 1999 Mar;30(3):352-5. Review.

PMID:
10088556
34.

Renal function after unilateral nephrectomy for Wilms' tumour: the influence of radiation therapy.

de Graaf SS, van Gent H, Reitsma-Bierens WC, van Luyk WH, Dolsma WV, Postma A.

Eur J Cancer. 1996 Mar;32A(3):465-9.

PMID:
8814694
35.

Vincristine disposition in children with acute lymphoblastic leukemia.

de Graaf SS, Bloemhof H, Vendrig DE, Uges DR.

Med Pediatr Oncol. 1995 Apr;24(4):235-40.

PMID:
7700168
36.

Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia.

Crom WR, de Graaf SS, Synold T, Uges DR, Bloemhof H, Rivera G, Christensen ML, Mahmoud H, Evans WE.

J Pediatr. 1994 Oct;125(4):642-9.

PMID:
7931891
37.

Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction.

Bloemhof H, Van Dijk KN, De Graaf SS, Vendrig DE, Uges DR.

J Chromatogr. 1991 Dec 6;572(1-2):171-9.

PMID:
1818052
38.

Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.

Houghton JA, Williams LG, de Graaf SS, Cheshire PJ, Rodman JH, Maneval DC, Wainer IW, Jadaud P, Houghton PJ.

Cancer Res. 1990 Jun 15;50(12):3493-502.

39.

Estimation of extracellular volume in preterm infants less than 1500 g, children, and adults by sucrose dilution.

Bauer K, Versmold H, Prölss A, De Graaf SS, Meeuwsen-Van der Roest WP, Zijlstra WG.

Pediatr Res. 1990 Mar;27(3):256-9.

PMID:
2181394
40.

Improved high-performance liquid chromatographic method using loop-column extraction for analysis of idarubicin and idarubicinol in plasma.

de Graaf SS, Riley-Stewart CA, Evans WE.

J Chromatogr. 1989 Jul 21;491(2):501-6. No abstract available.

PMID:
2808635
41.

Comparison of the conversion of 5-formyltetrahydrofolate and 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon tumors.

Houghton JA, Williams LG, de Graaf SS, Cheshire PJ, Wainer IW, Jadaud P, Houghton PJ.

Cancer Commun. 1989;1(3):167-74.

PMID:
2639728
42.
43.

Dissociation of body weight and lean body mass during cancer chemotherapy.

de Graaf SS, Meeuwsen-van der Roest WP, Schraffordt Koops H, Zijlstra WG.

Eur J Cancer Clin Oncol. 1987 Jun;23(6):731-7.

PMID:
3477460
44.

Influence of high-dose methotrexate on the distribution of body fluid volumes in the dog.

de Graaf SS, de Vries JA, Zijlstra WG.

Cancer Chemother Pharmacol. 1986;17(3):227-30.

PMID:
3742707
45.

Acute circulatory effects of doxorubicin in the conscious dog.

de Graaf SS, Nijmeijer A, Zijlstra WG.

Pediatr Hematol Oncol. 1986;3(4):311-8.

PMID:
3153244
46.

Unexpected cure in metastatic rhabdomyosarcoma.

de Graaf SS, Mehta DM, Molenaar WM, Vencken LM, Vermey A.

Arch Dis Child. 1985 May;60(5):482-4.

47.

[The changing role of thoracotomy in the treatment of metastatic tumors of the lung].

Homan van der Heide JN, Eijgelaar A, Prenger KB, Schraffordt Koops H, Oldhoff J, de Graaf SS, Kamps WA, Slejfer DT, Oosterhuis JW.

Rozhl Chir. 1984 Sep;63(8-9):539-46. Czech. No abstract available.

PMID:
6594771
48.

Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children.

Veth RP, De Graaf SS, Den Heeten GJ, Oldhoff J, Hoekstra HJ, Schraffordt Koops H, Nielsen HK.

J Surg Oncol. 1984 May;26(1):40-6.

PMID:
6587170
49.

Dislocation of an artificial knee component due to extraordinary function.

Veth RP, Nielsen HK, Keller H, Schraffordt Koops H, de Graaf SS, Goeken LN.

Arch Orthop Trauma Surg. 1984;103(5):356-8.

PMID:
6597702

Supplemental Content

Loading ...
Support Center